NAUT
Price
$0.75
Change
-$0.14 (-15.73%)
Updated
Apr 3 closing price
Capitalization
94.74M
32 days until earnings call
OVID
Price
$0.30
Change
-$0.04 (-11.76%)
Updated
Apr 3 closing price
Capitalization
21.42M
34 days until earnings call
Ad is loading...

NAUT vs OVID

Header iconNAUT vs OVID Comparison
Open Charts NAUT vs OVIDBanner chart's image
Nautilus Biotechnolgy
Price$0.75
Change-$0.14 (-15.73%)
Volume$251.54K
Capitalization94.74M
Ovid Therapeutics
Price$0.30
Change-$0.04 (-11.76%)
Volume$220.78K
Capitalization21.42M
NAUT vs OVID Comparison Chart
Loading...
NAUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OVID
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NAUT vs. OVID commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NAUT is a Hold and OVID is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (NAUT: $0.75 vs. OVID: $0.30)
Brand notoriety: NAUT and OVID are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NAUT: 194% vs. OVID: 52%
Market capitalization -- NAUT: $94.74M vs. OVID: $21.42M
NAUT [@Biotechnology] is valued at $94.74M. OVID’s [@Biotechnology] market capitalization is $21.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NAUT’s FA Score shows that 1 FA rating(s) are green whileOVID’s FA Score has 1 green FA rating(s).

  • NAUT’s FA Score: 1 green, 4 red.
  • OVID’s FA Score: 1 green, 4 red.
According to our system of comparison, both NAUT and OVID are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NAUT’s TA Score shows that 4 TA indicator(s) are bullish while OVID’s TA Score has 3 bullish TA indicator(s).

  • NAUT’s TA Score: 4 bullish, 2 bearish.
  • OVID’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, NAUT is a better buy in the short-term than OVID.

Price Growth

NAUT (@Biotechnology) experienced а -19.83% price change this week, while OVID (@Biotechnology) price change was -20.45% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.91%. For the same industry, the average monthly price growth was -11.19%, and the average quarterly price growth was -14.86%.

Reported Earning Dates

NAUT is expected to report earnings on May 06, 2025.

OVID is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-8.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NAUT($94.7M) has a higher market cap than OVID($21.4M). NAUT YTD gains are higher at: -55.298 vs. OVID (-67.720). OVID has higher annual earnings (EBITDA): -61.27M vs. NAUT (-75.12M). NAUT has more cash in the bank: 130M vs. OVID (53.1M). OVID has less debt than NAUT: OVID (14.8M) vs NAUT (30.5M). OVID has higher revenues than NAUT: OVID (566K) vs NAUT (0).
NAUTOVIDNAUT / OVID
Capitalization94.7M21.4M443%
EBITDA-75.12M-61.27M123%
Gain YTD-55.298-67.72082%
P/E RatioN/AN/A-
Revenue0566K-
Total Cash130M53.1M245%
Total Debt30.5M14.8M206%
FUNDAMENTALS RATINGS
NAUT vs OVID: Fundamental Ratings
NAUT
OVID
OUTLOOK RATING
1..100
5451
VALUATION
overvalued / fair valued / undervalued
1..100
13
Undervalued
30
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9697
PRICE GROWTH RATING
1..100
9597
P/E GROWTH RATING
1..100
10093
SEASONALITY SCORE
1..100
n/a35

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NAUT's Valuation (13) in the null industry is in the same range as OVID (30) in the Pharmaceuticals Major industry. This means that NAUT’s stock grew similarly to OVID’s over the last 12 months.

NAUT's Profit vs Risk Rating (100) in the null industry is in the same range as OVID (100) in the Pharmaceuticals Major industry. This means that NAUT’s stock grew similarly to OVID’s over the last 12 months.

NAUT's SMR Rating (96) in the null industry is in the same range as OVID (97) in the Pharmaceuticals Major industry. This means that NAUT’s stock grew similarly to OVID’s over the last 12 months.

NAUT's Price Growth Rating (95) in the null industry is in the same range as OVID (97) in the Pharmaceuticals Major industry. This means that NAUT’s stock grew similarly to OVID’s over the last 12 months.

OVID's P/E Growth Rating (93) in the Pharmaceuticals Major industry is in the same range as NAUT (100) in the null industry. This means that OVID’s stock grew similarly to NAUT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NAUTOVID
RSI
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
88%
Stochastic
ODDS (%)
N/A
N/A
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
81%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 19 days ago
81%
Bullish Trend 24 days ago
76%
Declines
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
88%
Aroon
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
85%
View a ticker or compare two or three
Ad is loading...
NAUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OVID
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TAIT2.29-0.07
-2.97%
Taitron Components
MBLY14.26-0.71
-4.74%
Mobileye Global
SNDR21.88-1.69
-7.17%
Schneider National
MHLD0.56-0.05
-7.97%
Maiden Holdings Ltd
HUT11.91-1.48
-11.05%
Hut 8 Corp

NAUT and

Correlation & Price change

A.I.dvisor indicates that over the last year, NAUT has been loosely correlated with FHTX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if NAUT jumps, then FHTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NAUT
1D Price
Change %
NAUT100%
-15.82%
FHTX - NAUT
50%
Loosely correlated
-7.89%
KYMR - NAUT
49%
Loosely correlated
-10.13%
TECH - NAUT
43%
Loosely correlated
-6.03%
FATE - NAUT
43%
Loosely correlated
-11.69%
AXON - NAUT
42%
Loosely correlated
-3.35%
More

OVID and

Correlation & Price change

A.I.dvisor indicates that over the last year, OVID has been closely correlated with AVTE. These tickers have moved in lockstep 90% of the time. This A.I.-generated data suggests there is a high statistical probability that if OVID jumps, then AVTE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OVID
1D Price
Change %
OVID100%
-11.35%
AVTE - OVID
90%
Closely correlated
-0.40%
SYRE - OVID
45%
Loosely correlated
-9.68%
NAUT - OVID
36%
Loosely correlated
-15.82%
TVTX - OVID
36%
Loosely correlated
-7.69%
NRIX - OVID
36%
Loosely correlated
-7.64%
More